Early stage IT and Healthcare Investing

Cidara

portfoliocompanies

company snapshot

Cidara

Cidara Therapeutics (Nasdaq: CDTX) is applying its small molecule immunotherapy platform to treat life-threatening illnesses exacerbated by deficiencies of the human immune system. Cidara's initial focus is on devastating fungal infections that often complicate cancer and transplant treatments.

Facebook Google+ Twitter Email LinkedIn Share